Ticker
006280
Analysis
Gc Biopharma Corp. (006280) Stock Analysis
Gc Biopharma Corp. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to 006280.
Gc Biopharma Corp.
Gc Biopharma Corp. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to 006280.
Stock profile
Asset type
Stock
Market cap
$962.9M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Currency
KRW
Ticker listings
Gc Biopharma Corp. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
- 006280 primary listing
Latest Gc Biopharma Corp. news
GC Biopharma Announces Lunch Symposium and Poster Presentations on IVIG Product Characterization at the 2026 CIS Annual Meeting
TEANECK, N.J., May 04, 2026--GC Biopharma Announces Lunch Symposium and Poster Presentations on IVIG Product Characterization at the 2026 CIS Annual Meeting
GC Biopharma Announces Presentation on Aggregation Profiles of Commercial IVIG Products at NHIA 2026
TEANECK, N.J., April 16, 2026--GC Biopharma Announces Presentation on Aggregation Profiles of Commercial IVIG Products at NHIA 2026
GC Biopharma Enhances IVIG Safety Profile with Advanced Prothrombotic Impurity Detection Technology
GC Biopharma (006280.KS), a global leader in plasma-derived protein therapies, today announced a significant advancement in the safety monitoring of intravenous immunoglobulin (...
GC Biopharma Receives Marketing Authorization for Varicella Vaccine 'BARYCELA Inj.' in Guatemala
GC Biopharma(006280.KS), a leading provider of biopharmaceutical products in South Korea, announced today that its varicella vaccine, BARYCELA Inj., has been granted marketing a...
GC Biopharma Publishes a Comprehensive Review Paper Summarizing 30 Years of Accumulated Data on Its Proprietary Varicella Vaccine Strain,...
GC Biopharma(006280.KS), a leading provider of biopharmaceutical products in South Korea, announced today that a review paper comprehensively analyzing the safety and immunogeni...
Research sections
Valuation
Review valuation context for Gc Biopharma Corp..
Future growth
Review future growth context for Gc Biopharma Corp..
Past performance
Review past performance context for Gc Biopharma Corp..
Financial health
Review financial health context for Gc Biopharma Corp..
Dividend
Review dividend context for Gc Biopharma Corp..
Management
Review management context for Gc Biopharma Corp..
Ownership
Review ownership context for Gc Biopharma Corp..
Other information
Review other information context for Gc Biopharma Corp..
Community
Review community context for Gc Biopharma Corp..